A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer (BL-AIR: Bladder Cancer-Avelumab for Invasive Resectable Disease)
Phase of Trial: Phase I/II
Latest Information Update: 22 Jan 2019
At a glance
- Drugs Avelumab (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 17 Sep 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Sep 2018 to 1 Oct 2018.
- 17 Sep 2018 Status changed from not yet recruiting to recruiting.
- 31 Aug 2018 Biomarkers information updated